期刊文献+

乙酰肝素酶shRNA双基因共表达真核载体的构建和筛选

Construction and identification of eukaryotic expression vector expressing double shRNA sections targeting heparanase gene
下载PDF
导出
摘要 目的:构建并筛选有效的、编码2条shRNA的乙酰肝素酶(Hpa)特异性基因真核表达载体.方法:分别设计、化学合成6对寡核苷酸单链,经退火、连接和磷酸化后得到Hpa shRNA双链,将两两随机问隔4~8个碱基后定向克隆入带有各自的U6启动子和终止码、共同的绿色荧光蛋白(green fluoreseent protein,EGFP)基因和Neo基因的pGenesil-1中,构建3条含两段Hpa基因shRNA的pGenesil-1-Hpa—shRNA真核表达载体,转染卵巢癌细胞株SKOV3,流式细胞仪和荧光显微镜下观察转染效率,免疫组化分析Hpa蛋白表达.结果:酶切与测序证实pGenesil-1-HPSE—shRNA构建成功,无任何碱基突变,3组质粒转染细胞均有Hpa表达的变化,3种不同shRNA质粒转染细胞后Hpa蛋白表达有明显差别.结论:构建并筛选了针对Hpa特异性的双基因shRNA真核表达载体pGenesil-1-Hpa-shRNA. AIM: To construct and identify eukaryotic expression vector expressing double shRNA sections targeting heparanase gene (Hpa-shRNA). METHODS: Six pairs of oligonucleotides were designed and chemically synthesized. After randomly connecting an oligonucleotide and another one with 4 -8 bases pairs interval, they were directionally inserted into plasmid pGenesil-1 with respectively U6 promoter and termination code, the common green fluorescence protein (EGFP) gene and Neo gene. In this way, 3 vectors of pGenesil-1-Hpa-shRNA containing 2 sections of Hpa-shRNA were constructed and they were transfected into the ovarian cancer cell SKOV3. The rate of transfection was detected by flow cytometry and fluorescence microscope. The inhibition effectiveness of Hpa protein was analyzed by immunohistochemical staining. RESULTS: The constructed eukaryotic expression vectors effectively suppressed the Hpa expression in transfected cells. The 3 vectors of different short hairpin RNA of Hpa effectively suppressed the expression in SKOV3 ( P 〈 0.01 ). CONCLUSION: We have constructed a eukaryotic expression vector of shRNA, specific for Hpa and have constructed and identified a eukaryotic expression vector of double-gene short hairpin RNA for Hpa.
出处 《第四军医大学学报》 北大核心 2006年第1期10-13,共4页 Journal of the Fourth Military Medical University
关键词 乙酰肝素酶 U6启动子 短发夹RNA 真核表达栽体 heparanase U6 promoter shRNA eukaryotic expression vector
  • 相关文献

参考文献10

  • 1Rye PD, Stigbrand T. Interfering with cancer: A brief outline of advances in RNA interference in oncology [J]. Tumor Biol, 2004,25:329 - 336.
  • 2Zhu J, Musco ML, Grace MJ. Three-color flow cytometry analysis of tricistronic expression of eBFP, eGFP, and eYFP using EMCV-IRES linkages [J]. Cytometry, 1999, 37:51 - 59.
  • 3Boyd DD, Nakajima M. Involvement of heparanase in tumor metastases: A new target in cancer therapy? [J]. J Natl Cancer Inst,2004,96:1194 - 1195.
  • 4Jiang M, Rubbi CP, Milner J. Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis[J]. Oligonucleotides, 2004, 14:239 - 248.
  • 5Scherr M, Battmer K, Schultheis B, et al. RNA interference(RNAi) as an option for anti-bcr-abl therapy [J]. Gene Ther,2005, 12:12 -21.
  • 6Ryther RC, Flynt AS, Phillips JA 3rd, et al. siRNA therapeutics:Big potential from small RNAs[J]. Gene Ther, 2005, 12:5 - 11.
  • 7Fougerolles A, Manoharan M, Meyers R, et al. RNA interference in vivo: Toward synthetic small inhibitory RNA-based therapeutics[J]. Methods Enzymol, 2005, 392:278-296.
  • 8Seki M,Iwakawa J, Cheng H, et al. p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferring-facilitated lipofection gene delivery strategy [J]. Hum Gene Ther, 2002, 13:761 - 773.
  • 9Paddison PJ, Caudy AA, Sachidanandam R, et al. Short hairpin activated gene silencing in mammalian cells [J]. Methods Mol Biol,2004,265:85 - 91.
  • 10郭颖,刘军,薛采芳,吴静,宋天保.人端粒酶催化亚单位mRNA的实时荧光RT-PCR定量检测[J].细胞与分子免疫学杂志,2004,20(5):618-620. 被引量:7

二级参考文献7

  • 1Blackburn EH. Switching and signaling at the telomere [J]. Cell,2001, 106:661 -673.
  • 2Chan SR, Blackburn EH. Telomeres and telomerase[J]. Philos Trans R Soc Loud B Biol Sci, 2004, 359:109 -121.
  • 3Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells[J].Nat Rev Immunol, 2002, 2: 699- 706.
  • 4Klein D. Quantification using real-time PCR technology: applications and limitations[ J]. Trends Mol Med, 2002, 8: 257- 260.
  • 5Gibson UEM, Heid CA, Williams PM. A novel method for real time quantitative RT-PCR [J]. Genome Res, 1996, 6:995 -1001.
  • 6Bieche I, Nogues C, Paradis V, et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay[ J]. Clin Cancer Res, 2000, 6:452 - 459.
  • 7Tchirkov A, Rolhion C, Kemeny JL, et al. Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas[J]. Br J Cancer, 2003, 88:516-520.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部